Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/licensing-partner-of-shenzhen-chipscreen-biosciences---huyabio-international-receives-regulatory-approval-for-chidamide-monotherapy-of-peripheral-t-cell-lymphomaptcl-in-japan-301435093.html

PRNEWSWIRE
01 Dec 2021